Nevertheless, the therapeutic effect of EGFR TKIs has not yet been reported [58–60], and Guo et al. found that TNF and EGFR inhibitors had a synergistic effect in TMZ-resistant glioblastoma. The gene discussed is EGFR; the disease is glioblastoma.